786 A randomized, double blind, placebo controlled phase II trial to evaluate the safety and efficacy of recMAGE-A3 + AS15 antigen specific cancer immunotherapy in patients with MAGE-A3 positive muscle invasive bladder cancer after cystectomy: An initial report of the EAU Research Foundation randomized phase II clinical trial ‘Magnolia’

✍ Scribed by Mulders, P.F.A.; Colombel, M.; Heidenreich, A.; Martínez-Piñeiro, L.; Babjuk, M.; Korneyev, I.; Surcel, C.; Yakovlev, P.; Colombo, R.; Radziszewski, P.; Witjes, J.A.; Schipper, R.; Witjes, W.P.J.; Steering Committee Magnolia,

• Book ID: 123459332
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 113 KB
• Volume: 13
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(14)60774-0